$1.04
-0.02-1.89%
Last update: Nov 2, 6:58 AM
Spero Therapeutics Inc (SPRO) Stock Price, Quote, News & History
SPRONASDAQ
Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.
Other companies in Spero Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Spero Therapeutics has a consensus price target of $5.67.
The stock price for Spero Therapeutics (NASDAQ: SPRO) is $1.12 last updated November 2, 2026 at 6:58 AM EST.
There are no upcoming dividends for Spero Therapeutics.
Spero Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Spero Therapeutics.
Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate,...
